Asarina And Emalex Carry The Torch For Tourette's
Alternatives To Antipsychotics Are Advancing
The pipeline to treat the neurological disorder, which is characterized by uncontrolled rapid and repeated movements or sounds, is very thin but a couple of biotechs either side of the Atlantic are making progress.
